美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Faeth Therapeutics

26.81

+2.8111.71%

成交量：6.88万

成交额：178.60万

市值：6.91亿

市盈率：-0.19

高：27.77

开：24.05

低：24.05

收：24.00

52周最高：36.76

52周最低：6.33

股本：2,577.88万

流通股本：81.17万

量比：0.77

换手率：8.48%

股息：- -

股息率：- -

每股收益(TTM):-142.7282

每股收益(LYR):-16.7239

净资产收益率：--

总资产收益率：-95.24%

市净率：-5.03

市盈率(LYR):-1.60

数据加载中...

总览公司新闻公告

Sensei Biotherapeutics：Piktor治疗HR+/HER2-晚期乳腺癌的1B/2期中期数据预计2027年公布

Sensei Biotherapeutics：Piktor治疗晚期子宫内膜癌的II期关键数据预计2026年下半年公布

Sensei Biotherapeutics任命Anand Parikh为董事长、总裁兼首席执行官，自2026年6月12日起生效

Sensei Biotherapeutics更名为Faeth Therapeutics，全力推进口服抗癌疗法Piktor

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/FTH/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":26.81,"timestamp":1782324153923,"preClose":24,"halted":0,"volume":68793,"delay":0,"changeRate":0.11708333333333328,"floatShares":811700,"shares":25778800,"eps":-142.7282,"marketStatus":"交易中","change":2.81,"latestTime":"06-24 14:05:14 EDT","open":24.05,"high":27.77,"low":24.05,"amount":1786008.956682,"amplitude":0.155,"askPrice":27.18,"askSize":10,"bidPrice":26.56,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-142.7282,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1782331200000},"marketStatusCode":2,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":24,"preHourTrading":{"tag":"盘前","latestPrice":23.11,"preClose":24,"latestTime":"09:22 EDT","volume":56,"amount":1337.459928,"timestamp":1782307368421,"change":-0.89,"changeRate":-0.037083,"amplitude":0.037083},"postHourTrading":{"tag":"盘后","latestPrice":23.6,"preClose":24,"latestTime":"18:34 EDT","volume":354,"amount":8404.327,"timestamp":1782254092105,"change":-0.4,"changeRate":-0.016667,"amplitude":0.016667},"volumeRatio":0.769879},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-95.24%","roe":"--","lyrEps":-16.72388,"volumeRatio":0.769879,"shares":25778800,"dividePrice":0,"high":27.77,"amplitude":0.155,"preClose":24,"low":24.05,"week52Low":6.325,"pbRate":"-5.03","week52High":36.76,"institutionHeld":0,"latestPrice":26.81,"committee":-0.666667,"eps":-142.7282,"divideRate":0,"volume":68793,"delay":0,"ttmEps":-142.7282,"open":24.05,"prevYearClose":10.67,"prevWeekClose":17.82,"prevMonthClose":21.14,"prevQuarterClose":31.52,"fiveDayClose":14.53,"twentyDayClose":16.47,"sixtyDayClose":27.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"盘前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"盘前","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91},{"market":"US","date":"2025-06-17","symbol":"FTH","defaultRemindTime":1750167000000,"type":"split","dateTimestamp":1750132800000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1782187200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-06-23","current":-0.187629,"percent":0,"low":-0.168709,"twenty":-0.145269,"median":-0.125386,"eighty":-0.114961,"high":-0.105707,"avg":-0.131297,"sd":0.023241,"marketCap":31119611},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-23","current":-0.168709,"twenty":-0.145269,"median":-0.125386,"eighty":-0.114961,"marketCap":31119611}],"updateTime":1782319165719},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTH\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155638133","title":"Sensei Biotherapeutics：Piktor治疗HR+/HER2-晚期乳腺癌的1B/2期中期数据预计2027年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1155638133","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155638133?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布，其候选疗法Piktor针对HR阳性、HER2阴性晚期乳腺癌的1B/2期临床试验中期数据，预计将于2027年获得。该数据将提供关于疗法安全性及初步疗效的关键见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197135575","title":"Sensei Biotherapeutics：Piktor治疗晚期子宫内膜癌的II期关键数据预计2026年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1197135575","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197135575?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布，其候选药物Piktor针对晚期子宫内膜癌的II期临床试验关键性数据，预计将于2026年下半年公布。这一时间表为关注该疗法进展的投资者和医学界提供了明确的时间节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110665123","title":"Sensei Biotherapeutics任命Anand Parikh为董事长、总裁兼首席执行官，自2026年6月12日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1110665123","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110665123?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 20:11","pubTimestamp":1781525508,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc. (SNSE) 宣布，自2026年6月12日起，Anand Parikh将正式出任公司董事长、总裁兼首席执行官。此项任命标志着公司领导层的重要更迭。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139331227","title":"Sensei Biotherapeutics更名为Faeth Therapeutics，全力推进口服抗癌疗法Piktor","url":"https://stock-news.laohu8.com/highlight/detail?id=1139331227","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139331227?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 20:10","pubTimestamp":1781525426,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc. 宣布将公司名称变更为Faeth Therapeutics。这一更名标志着公司战略重心聚焦于推进其核心候选药物Piktor的研发。Piktor是一种口服疗法，旨在靶向癌症中最常发生异常改变的信号通路之一。公司此举旨在更好地反映其专注于开发变革性癌症治疗药物的新方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH","SNSE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}